Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Schakowsky, Janice D. [D-IL-9]

Rep. Schakowsky, Janice D. [D-IL-9]

United States · Official source

Records

10,812 records where Rep. Schakowsky, Janice D. [D-IL-9] is listed as a sponsor, author, or other actor. Search with topics and years

Resolution· HRESH.Res. 473 (119th)referred

Calling for the urgent delivery and disbursement of humanitarian aid to address the needs of civilians in Gaza.

United States · United States Congress · 4 June 2025

This resolution expresses the House of Representatives' grave concern with (1) the humanitarian crisis and acute suffering of Palestinian civilians in Gaza, and (2) the suffering of the hostages and hostage families. The resolution also calls on the White House, the Department of State, and other relevant federal agencies to use all available diplomatic tools to bring about the release of the hostages, the disbursement of food and humanitarian aid to Palestinian civilians, and a durable end to the Gaza conflict.

Bill· HRH.R. 3740 (119th)referred

Equal Access to Justice for Victims of Gun Violence Act of 2025

United States · United States Congress · 4 June 2025

Equal Access to Justice for Victims of Gun Violence Act of 2025 This bill removes limitations on the civil liability of gun manufacturers and the disclosure of gun trace data in civil actions. Specifically, the bill repeals the Protection of Lawful Commerce in Arms Act, which prohibits civil actions against a firearm or ammunition manufacturer, seller, importer, dealer, or trade association for damages resulting from the criminal or unlawful misuse of a firearm. Additionally, the bill states that firearms trace data maintained by the Bureau of Alcohol, Tobacco, Firearms and Explosives is not immune from legal process. Such data is subject to discovery; is admissible as evidence; and may be used, relied on, or disclosed in a civil action or administrative proceeding.

Bill· HRH.R. 3694 (119th)referred

VALID Act of 2025

United States · United States Congress · 3 June 2025

Bill· HRH.R. 3607 (119th)referred

MARSHALS Act

United States · United States Congress · 23 May 2025

Bill· HRH.R. 3569 (119th)referred

Fit to Serve Act

United States · United States Congress · 21 May 2025

Bill· HRH.R. 3565 (119th)referred

To provide for a limitation on the transfer of defense articles and defense services to Israel.

United States · United States Congress · 21 May 2025

This bill prohibits the President from selling, transferring, or exporting certain defense articles or services to Israel, except in specified circumstances.  Defense articles covered by the prohibition include BLU-109 bunker busting bombs, Joint Direct Attack Munition (JDAM) assemblies, and 155mm artillery ammunition. Defense services directly related to such articles are also covered.  The President may sell, transfer, or export such defense articles or services to Israel if (1) a law is enacted specifying the purposes for which such articles or services may be used, and (2) Israel provides written assurances that the defense articles or services will be used for those specific statutory purposes and in a manner consistent with certain other laws, including international human rights laws. 

Bill· HRH.R. 3543 (119th)referred

College for All Act of 2025

United States · United States Congress · 21 May 2025

College for All Act of 2025 This bill establishes measures to expand access to higher education, including by eliminating tuition and required fees for eligible students, revising the Federal Pell Grant program, and reauthorizing certain programs to assist students from disadvantaged backgrounds. Specifically, the bill provides funding to enable states and tribal colleges and universities, through a federal-state partnership, to eliminate tuition and required fees for (1) all students at community colleges and two-year tribal colleges and universities, and (2) working- and middle-class students at four-year public institutions of higher education and tribal colleges and universities. The bill provides funding to enable private, nonprofit historically Black colleges and universities and minority-serving institutions to eliminate tuition and required fees for eligible students. The bill permanently reauthorizes and otherwise revises the Federal Pell Grant program by providing funding to increase the maximum award for each eligible student, increasing the duration limit for the use of Pell Grants, allowing students to use their awards to cover living and nontuition expenses, and expanding eligibility to Dreamer students (i.e., students who have been granted Deferred Action for Childhood Arrivals status and who entered the United States before the age of 16) and students with other immigration statuses. Further, the bill requires the Department of Education to award grants to eligible states and tribal colleges and universities for improving student outcomes. The bill reauthorizes through FY2035 the Federal TRIO Programs and reauthorizes through FY2029 the Gaining Early Awareness and Readiness for Undergraduate Programs.

Bill· HRH.R. 3546 (119th)referred

Prescription Drug Price Relief Act of 2025

United States · United States Congress · 21 May 2025

Prescription Drug Price Relief Act of 2025 This bill requires the Department of Health and Human Services (HHS) to review brand-name drugs annually for excessive pricing and, if a drug is found to be priced excessively, to void any exclusivity granted to its sponsor. Specifically, HHS must review all brand-name drug prices at least annually and upon petition. If any such drugs are found to be excessively priced, HHS must (1) void any government-granted exclusivity; (2) issue open, nonexclusive licenses for the drugs; and (3) expedite the review of corresponding applications for generic drugs and biosimilar biological products. HHS must also create a public database with its determinations for each drug. An entity accepting an open, nonexclusive license under these provisions must pay a reasonable royalty to the holder of the relevant patent or approved new drug application, and must price the generic drug or biosimilar below the excessive rate. Under the bill, a price is considered excessive if the domestic average manufacturing price exceeds the median price for the drug in Canada, the United Kingdom, Germany, France, and Japan. If a price does not meet this criteria, or if pricing information is unavailable in at least three of these countries, the price is still considered excessive if it is higher than reasonable in light of specified factors, including development cost, revenue, and the size of the affected patient population. The bill also requires drug manufacturers to report specified financial information for brand-name drugs, including research and advertising expenditures.

Bill· HRH.R. 3514 (119th)reported

Improving Seniors’ Timely Access to Care Act of 2025

United States · United States Congress · 20 May 2025

Improving Seniors' Timely Access to Care Act of 2025 This bill establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans. Specifically, MA plans must (1) establish an electronic prior authorization program that meets specified standards; (2) annually submit to the CMS for publication specified prior authorization information, including the percentage of requests approved and the average response time; and (3) meet other standards, as set by the Centers for Medicare & Medicaid Services (CMS), relating to the quality and timeliness of prior authorization determinations. The CMS and the Office of the National Coordinator for Health Information Technology must publish on the CMS' website a report that analyzes the information received from MA plans, the feasibility of implementing real-time decision making with respect to prior authorization requests, and the impact of decisions that are made using artificial intelligence on patient access. 

Bill· HRH.R. 3449 (119th)referred

Stronger Communities through Better Transit Act

United States · United States Congress · 15 May 2025

Stronger Communities through Better Transit Act This bill requires the Department of Transportation (DOT) to establish a grant program to support operating projects for public transportation and related service improvements, particularly in underserved communities and areas of persistent poverty. Specifically, the bill requires DOT to allocate funding under the program for urbanized areas, states, and Indian tribes that are recipients of funds under either the Federal Transit Administration's (FTA's) Urbanized Area Formula Funding program or Formula Grants for Rural Areas program. Eligible recipients may use funding for operating costs associated with projects that improve public transportation service for transit-dependent populations and support increased transit ridership (e.g., service expansion, information technology enhancements, and workforce development). DOT must apportion the funding so that recipients receive funds that are proportional to their share of operating costs. The bill also provides for an increased federal cost share for operating assistance for projects or programs carried out in areas of persistent poverty or underserved communities. DOT must set up a multimodal access measurement interface for public agencies to aid transit agencies in determining and reporting on access to jobs and essential services. A grant recipient must (1) report specific information to the FTA for inclusion in the National Transit Database, and (2) survey transit riders and non-riding residents regarding transit service improvements. Further, the bill expands the purposes of the public transportation programs to include supporting public transportation's role in combating climate change through growing/retaining transit ridership.

Bill· HRH.R. 3415 (119th)referred

Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2025

United States · United States Congress · 14 May 2025

Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2025 This bill requires hospitals to implement and submit to the Department of Health and Human Services (HHS) a staffing plan that complies with specified minimum nurse-to-patient ratios by unit. Hospitals must post a notice regarding nurse-to-patient ratios in each unit and maintain records of actual ratios for each shift in each unit. The bill also requires hospitals to follow certain procedures regarding how ratios are determined, and other staff are prohibited from performing nurse functions unless specifically authorized within a state's scope of practice rules. HHS must adjust Medicare payments to hospitals to cover additional costs attributable to compliance with these ratios. Nurses may object to, or refuse to participate in, an assignment if it would violate minimum ratios or if they are not prepared by education or experience to fulfill the assignment without compromising the safety of a patient or jeopardizing their nurse's license. Hospitals may not (1) take adverse actions against a nurse based on the nurse's reasonable refusal to accept an assignment; or (2) discriminate against individuals for good faith complaints relating to the care, services, or conditions of the hospital or related facilities. HHS may impose civil monetary penalties on hospitals violating the ratio requirements and must publish the names of such hospitals. The bill provides stipends to the nurse workforce loan repayment and scholarship program and expands the nurse retention grant program to include nurse preceptorship and mentorship projects.

Bill· HRH.R. 3184 (119th)referred

PFAS Alternatives Act

United States · United States Congress · 5 May 2025

Bill· HRH.R. 3162 (119th)referred

Affordable and Safe Prescription Drug Importation Act of 2025

United States · United States Congress · 1 May 2025

Affordable and Safe Prescription Drug Importation Act of 2025 This bill expands the categories of prescription drugs that may be imported into the United States and the countries from which such drugs may be imported. Current law allows the Department of Health and Human Services (HHS) to authorize importation of certain eligible prescription drugs from Canada if HHS certifies that doing so would pose no additional risk to public health and safety, among other requirements. HHS long declined to make the requisite certification, citing safety concerns (e.g., contamination, counterfeiting), but ultimately made the certification in 2020 and has since approved one state plan to import drugs. The bill removes the certification requirement and requires HHS to issue regulations that permit importation of qualifying prescription drugs from the United Kingdom, Switzerland, and member states of the European Union, in addition to Canada. After one year, if HHS determines that importation of drugs from these countries has been conducted safely, HHS may authorize importation from other countries that meet certain requirements. The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin. Further, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS. Finally, the bill imposes criminal penalties for websites that sell counterfeit drugs or dispense drugs without a required prescription.

Bill· HRH.R. 3164 (119th)reported

Ensuring Community Access to Pharmacist Services Act

United States · United States Congress · 1 May 2025

Ensuring Community Access to Pharmacist Services Act This bill provides for permanent coverage under Medicare of certain pharmacist services. Specifically, the bill provides for permanent coverage of testing and treatment services provided by pharmacists relating to (1) COVID-19, influenza, respiratory syncytial virus (RSV), and streptococcal pharyngitis (strep throat); and (2) other public health needs in relation to a declared public health emergency. (Similar authorities were temporarily granted during the COVID-19 public health emergency.) Such services must be provided in accordance with the applicable state laws governing pharmacists' scope of practice.

Bill· HRH.R. 3115 (119th)referred

Assault Weapons Ban of 2025

United States · United States Congress · 30 April 2025

Assault Weapons Ban of 2025 This bill makes it a crime to knowingly import, sell, manufacture, transfer, or possess a semiautomatic assault weapon (SAW) or large capacity ammunition feeding device (LCAFD). The prohibition does not apply to a firearm that is (1) manually operated by bolt, pump, lever, or slide action, except for certain shotguns; (2) permanently inoperable; (3) an antique; (4) only capable of firing rimfire ammunition; or (5) a rifle or shotgun specifically identified by make and model. The bill also exempts from the prohibition the following, with respect to a SAW or LCAFD: importation, sale, manufacture, transfer, or possession related to certain law enforcement efforts, or authorized tests or experiments; importation, sale, transfer, or possession related to securing nuclear materials; and possession by a retired law enforcement officer. The bill permits continued possession, sale, or transfer of a grandfathered SAW, which must be securely stored. A licensed gun dealer must conduct a background check prior to the sale or transfer of a grandfathered SAW between private parties. The bill permits continued possession of, but prohibits sale or transfer of, a grandfathered LCAFD. Newly manufactured LCAFDs must display serial number identification. Newly manufactured SAWs and LCAFDs must display the date of manufacture. The bill also allows a state or local government to use Edward Byrne Memorial Justice Assistance Grant Program funds to compensate individuals who surrender a SAW or LCAFD under a buy-back program.

Bill· HRH.R. 3104 (119th)referred

Ukrainian Adjustment Act of 2025

United States · United States Congress · 30 April 2025

Ukrainian Adjustment Act of 2025 This bill provides a streamlined process for certain Ukrainian nationals (including accompanying spouse and children) who are living in the United States to receive lawful permanent resident status. Specifically, the bill permits Ukrainian nationals who have been paroled into the United States after February 20, 2014, to apply for and receive lawful permanent resident status. Additionally, the Department of Homeland Security (DHS) may waive grounds for inadmissibility (excluding certain crimes or security related grounds) for individuals who apply for status adjustment. DHS must establish vetting requirements (including an interview) for applicants that are equivalent to those under the United States Refugee Admissions Program. The bill also preserves eligibility for the status adjustment of certain battered spouses whose eligibility for such status stemmed from a marriage that has terminated. Finally, the bill requires DHS to issue guidance to implement these requirements and establishes a deadline for eligible individuals to apply for adjustment.

Bill· HRH.R. 3121 (119th)referred

Anna’s Law of 2025

United States · United States Congress · 30 April 2025

Bill· HRH.R. 15 (119th)referred

Equality Act

United States · United States Congress · 29 April 2025

Equality Act This bill prohibits discrimination based on sex, sexual orientation, or gender identity with respect to businesses, employment, housing, federally funded programs, and other settings. Specifically, the bill expands Title II and Title VI of the Civil Rights Act of 1964 to prohibit public accommodations and federally funded programs, respectively, from discriminating based on sex, sexual orientation, or gender identity. It also includes stores, transit services, recreational facilities, and establishments that provide health care, accounting, or legal services as public accommodations under Title II. The bill also expands Title IV (desegregation of public schools) and Title VII (employment discrimination) to specifically include sexual orientation and gender identity. (The Supreme Court held in Bostock v. Clayton County that Title VII's prohibition of employment discrimination based on sex also prohibits employment discrimination based on sexual orientation or gender identity.) The bill similarly expands the Fair Housing Act (discrimination in public and private housing) to include sexual orientation and gender identity. It also prohibits discrimination based on sexual orientation or gender identity by creditors and with respect to jury selection. The bill defines sex for purposes of the aforementioned provisions to include sex stereotypes, pregnancy, childbirth, sexual orientation, gender identity, and sex characteristics.